US Broker Ratings

Revvity, Inc. (RVTY) Stock Analysis: Healthcare Innovator with a 31.44% Upside Potential

Revvity, Inc. (NYSE: RVTY), a prominent player in the healthcare sector, specifically within diagnostics and research, is garnering attention for its robust potential upside and strategic role in healthcare innovation...

Bio-Rad Laboratories, Inc. (BIO) Investor Outlook: Navigating the 11.58% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a stalwart in the healthcare sector with a focus on medical devices, offers an intriguing proposition for investors seeking exposure to the life sciences and..

McKesson Corporation (MCK) Stock Analysis: Exploring a Potential 21.73% Upside Amid Robust Revenue Growth

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, continues to solidify its position as a leading provider of medical distribution services. With a market capitalization of $99.71 billion,..

Option Care Health, Inc. (OPCH) Investor Outlook: Evaluating a 53% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a prominent player in the healthcare sector, particularly in the medical care facilities industry, presents an intriguing investment opportunity with a compelling potential upside..

Charles River Laboratories (CRL) Stock Report: Analyst Consensus and 20% Upside Potential

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. This Massachusetts-based company is known for its..

Jazz Pharmaceuticals plc (JAZZ): Investor Outlook with a Promising 11.54% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), an innovative player in the biotechnology sector, is catching investor attention with its promising growth trajectory and a potential upside of 11.54%. Headquartered in Dublin,..

Ionis Pharmaceuticals, Inc. (IONS) Investor Outlook: A 33.82% Upside Potential Beckons in the Biotech Sector

Ionis Pharmaceuticals, Inc. (IONS), a key player in the biotechnology sector, is commanding attention from investors with a market cap of $12.44 billion. Known for its pioneering RNA-targeted medicines, Ionis..

Insmed Incorporated (INSM): Analyst Consensus Signals a Potential 59.61% Upside for Investors

Insmed Incorporated (NASDAQ: INSM), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising pipeline of therapies for serious and rare diseases. With..

Vertex Pharmaceuticals (VRTX) Stock Report: Analyzing a 29.33% Upside Potential

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) stands as a beacon in the biotechnology sector, with a market capitalization of $107.83 billion. Known for its groundbreaking treatments for serious diseases, Vertex has..

Stevanato Group S.p.A. (STVN) Stock Analysis: A 39.59% Potential Upside in the Healthcare Sector

Stevanato Group S.p.A. (NYSE: STVN), an Italian powerhouse in the healthcare industry, stands out as a compelling investment opportunity with a notable potential upside of 39.59%. With a market capitalization..

Teleflex Incorporated (TFX) Stock Analysis: Navigating a 9.04% Upside Amidst Healthcare Sector Dynamics

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, remains a focal point for investors seeking exposure in the medical instruments and supplies industry. With a market capitalization..

Waystar Holding Corp. (WAY) Stock Analysis: A 68% Upside Potential Awaits Investors

Waystar Holding Corp. (NASDAQ: WAY), a burgeoning player in the healthcare information services sector, presents an intriguing opportunity for investors seeking growth in the tech-driven healthcare domain. With a market..

Agilent Technologies, Inc. (A) Stock Analysis: A Promising 40% Upside Potential for Investors

Agilent Technologies, Inc. (NYSE: A) has long been a stalwart in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $32.36 billion, this American..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Exploring a 26% Upside Potential in the Healthcare Sector

For investors keeping an eye on the healthcare sector, Intuitive Surgical, Inc. (NASDAQ: ISRG) presents a compelling opportunity. With a market capitalization of $162.13 billion, this leader in medical instruments..

Merit Medical Systems, Inc. (MMSI): Investor Outlook on a Potential 46% Upside

Merit Medical Systems, Inc. (NASDAQ: MMSI), a leader in the healthcare sector specializing in the design and production of single-use medical products, presents a compelling investment opportunity with a potential..

Stryker Corporation (SYK) Stock Analysis: Unpacking a 33.72% Potential Upside for Investors

Investors with an eye on the healthcare sector would do well to consider Stryker Corporation (NYSE: SYK), a leading player in the medical devices industry with a market capitalization of..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating a Potential 18.85% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH), a prominent player in the healthcare sector specializing in medical devices, presents a compelling case for investors seeking exposure to the orthopedic and reconstructive..

Solventum Corporation (SOLV) Stock Analysis: Unraveling a 26% Upside Potential in the Healthcare Sector

Solventum Corporation (NYSE: SOLV), a prominent player in the healthcare sector, is drawing attention from investors with its robust presence in the medical instruments and supplies industry. Headquartered in Eagan,..

BridgeBio Pharma (BBIO) Stock Analysis: Exploring a 47.59% Potential Upside in the Biotech Sector

BridgeBio Pharma, Inc. (NASDAQ: BBIO) stands at the forefront of the biotechnology industry, captivating investor attention with its innovative approach to treating genetic diseases. With a staggering market capitalization of..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: Uncovering a Potential 40.88% Upside in the Healthcare Sector

Neurocrine Biosciences, Inc. (NBIX) stands out as a promising player in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a robust market capitalization of $13.25..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds